key: cord-0067956-zuquo414 authors: Vatansever, Mustafa; Dursun, Özer; Özer, Ömer; Oktay, Özgün; Dinç, Erdem title: A Rare Ocular Complication of Autologous Fat Injection: Subconjunctival Fat Infiltration date: 2021-07-09 journal: J Craniofac Surg DOI: 10.1097/scs.0000000000007924 sha: 8c4dfbdcb5ede6df4eb4c1a3cb092fd2610898e4 doc_id: 67956 cord_uid: zuquo414 The aim of this brief clinical study to describe and discuss the subconjunctival fat infiltration encountered in a patient with autologous fat injection. A 50-year-old female patient, who had an autologous fat injection 2 days ago, applied to our clinic with the complaint of redness and burning in the left eye. On anterior segment examination, a raised 20 × 15 mm adipose tissue was observed in the temporal region under the conjunctiva. Infiltrated fat tissue was surgically removed from the subconjunctival area. Subconjunctival fat infiltration is an extremely rare complication after autologous fat injection. O ne year has passed since the detection of coronavirus disease 2019 (COVID- 19) , and the identification of its causative virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus belongs to the coronaviruses family which are singlestranded large RNA spherical viruses, that are covered with a helically symmetrical capsid and a pericapsid crossed by glycoproteins giving it the characteristic ''crown'' appearance. 1, 2 The main mode of virus transmission is close or direct contact with infected secretions or respiratory droplets produced by coughing, sneezing, or talking. 1 Therefore, the use of face masks is the recommended protective measure in healthcare settings and in general population, with the use of eye protection being an additionally beneficial measure. 3 Further, the virus may persist on various surfaces for durations that can reach up to days making transmission via these contaminated surfaces a possibility. 4 Several clinical manifestations of the disease are identified mainly as respiratory symptoms in the form of pneumonia and acute respiratory distress syndrome in the majority of patients. Systemic manifestations are noticed as with many viral infections SARS-CoV-2 infection in the form of fever, dry cough, myalgia, and fatigue. 5 The highly transmissible virus also affects extrapulmonary organs which may be irreversibly damaged on many occasions with subsequent serious complications that may persist for a relatively long period of time. Severe acute respiratory syndrome coronavirus 2 infection was shown to have hematologic, cardiovascular, renal, gastrointestinal, hepatobiliary, endocrine, neurologic, and mucocutaneous complications. 6 Furthermore, the adverse health and economic impact of COVID-19 pandemic influenced mental health causing distress, anxiety, and depression. Such complications can adversely affect patients' health attitudes towards obtaining healthcare services increasing risk of worsened disease outcomes. 7 These complications are not necessarily shortlived, thereby scientists have warned against the anticipated longterm effects of multiorgan injury following COVID-19 infections. 6 During these critical times maxillofacial surgeons may encounter patients who recovered from COVID-19; whereas some of them may have recovered completely, others may be suffering long-term morbidities as a result of this incompletely understood infection. During the first few months of the pandemic many dental associations including the American Dental Association requested dental practitioners to refrain from providing dental treatment to their patients unless an emergency situation is encountered or an urgent treatment is needed. 8 Later, dental practices were allowed to open once again to their patients although numbers of new and critical cases have surged in many countries. 9 At mid-December 2020, almost 1 year after the detection of first cases of this pandemic, there are globally more than 70 million cases, and more than 1.5 million deaths affecting more than 200 countries. 10 This will increase the odds for maxillofacial surgeons to encounter patients who are completely or partially recovered from COVID-19 and its plethora of complications. Maxillofacial surgeons have to be aware of the various systemic complications that recovered COVID-19 patient may have, and should understand how these might interfere with the treatment plan, in terms of introducing required modifications and precautions. This is particularly very important taking into consideration the rapid rise of infections detected worldwide, and the expected increase in the rate of morbidities due to insufficient capacity of healthcare systems in many countries to meet the increasing demands related to pandemic spread. 11 The aim of this report is to discuss the long-term systemic complications of COVID-19 that were documented so far in relation to their potential influence on treatment planning in maxillofacial surgery with particular reference to precautions and modifications (Fig. 1 ). Many COVID-19 patients experience persistent respiratory symptoms in the form of chronic cough, fibrotic lung disease, bronchiectasis, and pulmonary vascular disease. 12 Consequently, authorities like the British Thoracic Society issued a recommendation to request chest radiograph 3 months after discharge for all hospitalized COVID-19 patients, and confirmed the need for follow-up and further investigations for some categories of patients. 13 It is important for the maxillofacial surgeons to notice that consultation with the patient physician may be required, and patients may need further assessment like requesting chest radiograph and oxygen saturation measurements before maxillofacial surgical procedures particularly for patients requiring lengthy procedures, or procedures performed under general anesthesia. Coronavirus disease 2019 can be associated with cardiovascular complications either due to the interaction between virus and heart tissue or as a consequence of pharmacologic agents used in its treatment. Cardiovascular disorders complicating SARS-CoV-2 infection were reported to be myocardial injury, acute coronary syndrome, venous thromboembolism, and arrhythmias. 14 Development of cardiovascular disorders can also be seen in children with COVID-19 in the form of Kawasaki disease presenting as cardiac dysfunction and coronary vascular abnormalities. 1 Although disease outcomes of COVID-19 are worsened by a pre-existing cardiovascular disease, the associated high burden of systemic inflammation is thought to be the main factor that predisposes to the development of subclinical disorders or even causes de novo cardiovascular damage. 15 Approximately 1 in 5 patients with COVID-19 experiences de novo myocardial injury, which may remain as a chronic consequence of the disease, 16 or worse, could be identified as a cause of mortality. 17 Beyond myocardial injury, an interesting recent study on 4 cases of COVID-19 found that 1 patient, with no prior history of heart disease, developed a vegetation in the tricuspid valve and severe tricuspid regurgitation. 17 It was noted that patients infected with SARS-CoV have also developed endocarditis with vegetations in previous reports. 18 This may have important implications for the recovered COVID -19 patient in the maxillofacial surgery setting. Although there are no data yet on the long-term nature of cardiac injury including valvular tissue, it is important to exclude cardiac conditions before delivering oral health care for the recovering COVID 19 patient. Infectious endocarditis is a serious complication that results from bacterial or fungal infection of the endocardial surface of the heart and is associated with significant morbidity and mortality. 19 Although this infection could follow bacteremia resulting from certain maxillofacial surgical procedures in susceptible patients, it could also be attributed to low-grade, repeated bacteremia that results from daily routine practices such as oral hygiene activities, and mastication in patients with poor oral hygiene 20 The kidney may be one of the targets of SARS-CoV-2 infection through the interaction between the virus and the abundant angiotensin-converting enzyme-2 (ACE-2) receptors in the kidney. Acute kidney injury in COVID-19 could affect up to 29% of patients. 21 Unfortunately, there is a high level of residual kidney dysfunction in patients who have recovered from COVID-19, with a possible risk for progression to end-stage kidney disease. 22 In such patients, there should be monitoring of drug prescriptions based on their safety profile. The first choice analgesic is paracetamol which is metabolized mainly in the liver with only 2% to 5% of the dose being excreted unchanged in the urine, hence there are no clinically significant changes observed in patients with kidney failure. 23 Furthermore, recent evidence suggests that lifetime cumulative doses of paracetamol do not have an adverse effect on progression rate of chronic renal disease, 24 however, the maximum daily dose should not exceed 3000 mg to avoid liver injury. 23 Maxillofacial surgeons may consider nonsteroidal anti-inflammatory agents in certain situations of acute or more severe orofacial pain, taking into consideration the use of the lowest effective dose and shortest possible duration. 25 As for antibiotic prescribing, a number of antibiotics are considered relatively safe that do not require dose modification including clindamycin, metronidazole, and macrolides like azithromycin. 26 Liver damage or dysfunction (mainly characterized by moderately elevated serum aspartate aminotransferase levels) have been reported among patients with COVID-19. The mechanism of injury is not well understood and although ACE-2 receptor is highly expressed in bile duct cells, it seems that SARS-CoV-2 infection does not cause bile duct injury. 27 It is estimated that nearly 37% of COVID-19 patients had liver dysfunction upon admission, 27 however, COVID-19-related liver injury is thought to be relatively mild, with severe affection being noticed in patients with pre-existing chronic liver disease. 28 Occurrence of de novo liver function tests abnormality was common in hospitalized patients, and it was associated with the use of potentially hepatotoxic drugs, such as paracetamol, antivirals, and antibiotics. 29 Unfortunately, it was noticed that lock-down and limited activities in dental practices linked to the COVID-19 pandemic were associated with increased antibiotic prescribing. 30 This necessitates antibiotic stewardship to mitigate the likely consequences of antibiotic prescribing including the increased rate of antibiotics side effects and increased antibiotic resistance. 31 The possible influence of antibiotics consumption namely amoxicillin/clavulanic acid, and analgesics namely paracetamol on the picture of liver function tests in COVID-19 patients should alert maxillofacial surgeons to be cautious in their prescribing and to closely monitor their patients postoperatively. It may be necessary to request liver function tests in suspected cases before prescribing certain drugs. On the other hand, administration of local anesthesia should utilize local anesthetics that are not dependent on the liver for their metabolism. Articaine which is metabolized in plasma is a preferable choice, and if the patient has normal respiratory functions, prilocaine which is metabolized in the lungs could also be used. 32 Coronavirus disease 2019 may predispose patients to venous and arterial thrombosis due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. 33 The duration of thrombotic derangements after recovering from the symptoms of COVID-19 is unclear, hence some authorities recommended extended prophylaxis with anticoagulants after hospital discharge for a duration of 4 to 6 weeks determined by each patient's specific medical condition. 33 Patients who are recently recovered from COVID-19 may need to be further investigated for coagulopathy if they are to receive surgical manipulation of the oral cavity including prothrombin time or international normalized ratio. Severe acute respiratory syndrome coronavirus 2 is known to bind to ACE-2 receptors abundant in pancreatic beta cells, producing a reduced insulin secretion, hence, it is possible that it may cause alterations of glucose metabolism that could complicate a pre-existing diabetes or lead to new-onset disease. 34 However, there are several questions that need to be answered regarding this association including: the long-standing, or self-limiting nature; diabetes type in the affected patients; and anticipated severity of disease-related complications. 34 Maxillofacial surgeons should perform thorough screening of patients previously infected with COVID-19 during taking medical history by asking about symptoms of diabetes like thirst and fatigue, and may extend their screening to requesting the necessary laboratory tests to detect hyperglycemia. Furthermore, some researchers hypothesized that other glands could be adversely affected by SARS-CoV-2 infection such as the thyroid or adrenal gland, 35 which necessitates bearing this in mind while providing management to the recovered COVID-19 patient. Thorough medical history should be obtained from recovering COVID 19 patients who require maxillofacial surgical interventions to exclude possible persistent organ dysfunction complicating the viral infection. A triage method was proposed to assess patients' Getting to know SARS-CoV-2: towards a better understanding of the factors influencing transmission. Pesqui Bras Odontopediatria Clín Integr SARS-CoV-2 persistence: data summary up to Q2 2020 Covid-19 pandemic: the use of protective visor in the dentistry degree course of dental prosthetics technology of the University of Messina COVID-19 surface persistence: a recent data summary and its importance for medical and dental settings Fallacies and facts around COVID-19: the multifaceted infection Extrapulmonary manifestations of COVID-19 Psychological functioning of patients undergoing oral surgery procedures during the regime related with SARS-CoV-2 pandemic COVID-19: present and future challenges for dental practice Factors influencing global variations in COVID-19 cases and fatalities; a review COVID-19 and its challenges for the healthcare system in Pakistan Long term respiratory complications of COVID-19 British Thoracic Society Guidance on Respiratory Follow Up of Patients with a Clinico-Radiological Diagnosis of COVID-19 Pneumonia COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives Potential effects of coronaviruses on the cardiovascular system: a review COVID-19 and the cardiovascular system Echocardiographic characteristics of subjects with COVID-19: a case series Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis Infectious endocarditis: diagnosis and treatment Bacteremia associated with toothbrushing and dental extraction Management of acute kidney injury in COVID-19 COVID-19 and the kidney: what we think we know so far and what we don't Clinical pharmacology considerations in pain management in patients with advanced kidney failure Acetaminophen, aspirin and progression of advanced chronic kidney disease A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly Nephrology: 3. Safe drug prescribing for patients with renal insufficiency Clinical features of COVID-19-related liver functional abnormality Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 Utilization of teledentistry in antimicrobial prescribing and diagnosis of infectious diseases during COVID-19 lockdown Online ahead of print Antibiotic prescribing for oro-facial infections in the paediatric outpatient: a review Manejo odontológico en el paciente cirrótico COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review New-onset diabetes in COVID-19 Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands? COVID-19 pandemic and telephone triage before attending medical office: problem or opportunity?